STOCK TITAN

VIVOS president buys 25,550 shares on market

VIVOS INC’s president bought 25,550 RDGL shares in the open market, lifting his direct holdings to over 1.54 million shares.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VIVOS INC (RDGL) President Brad Allan Weeks reported an open-market purchase of 25,550 shares of common stock on September 16, 2026 at a weighted average price of $0.0482 per share, with individual trade prices ranging from $0.048 to $0.0489. Following this transaction, he directly holds 1,547,204 shares of VIVOS INC common stock. No Rule 10b5-1 trading plan is reported for this purchase.

Positive

  • None.

Negative

  • None.
Insider Weeks Brad Allan
Role President
Bought 25,550 shs ($1K)
Type Security Shares Price Value
Purchase Common Stock F1 25,550 $0.0482 $1K
Holdings After Transaction: Common Stock — 1,547,204 shares (Direct)
Footnotes (1)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.048 to $0.0489, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) of this Form 4.
Shares purchased 25,550 shares Common stock bought by the President on September 16, 2026
Weighted average purchase price $0.0482 per share Average price for the 25,550 shares purchased
Purchase price range $0.048 to $0.0489 per share Range of individual trade prices in the September 16, 2026 purchase
Shares owned after transaction 1,547,204 shares Direct holdings of Brad Allan Weeks following the reported trade
Number of buy transactions 1 Count of purchase transactions in this Form 4
Net buy/sell shares 25,550 shares (net buy) Net share change from all reported transactions in this filing
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"Purchase in open market or private transaction"
Rule 10b5-1 regulatory
"the staff of the Securities and Exchange Commission, upon request"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VIVOS INC (RDGL) report on this Form 4?

VIVOS INC reported that President Brad Allan Weeks purchased 25,550 shares of common stock on September 16, 2026 in an open-market transaction, increasing his direct ownership in the company.

At what price did the RDGL insider buy shares on September 16, 2026?

The insider purchase was reported at a weighted average price of $0.0482 per share. A footnote explains the shares were bought in multiple trades at prices ranging from $0.048 to $0.0489 per share, inclusive.

How many RDGL shares does the VIVOS INC president own after this transaction?

After the September 16, 2026 purchase, President Brad Allan Weeks directly owns 1,547,204 shares of VIVOS INC common stock, as reported in the Form 4 filing.

Was the RDGL insider purchase made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not marked, and there is no footnote stating that the September 16, 2026 purchase was made pursuant to a Rule 10b5-1 trading plan.

What type of transaction code is reported for the RDGL insider trade?

The Form 4 uses transaction code P, which indicates a purchase in an open market or private transaction. The reported transaction is a non-derivative acquisition of common stock.

Is this RDGL Form 4 transaction a buy or a sell overall?

Overall, the reported activity is a net buy. The summary shows 1 purchase totaling 25,550 shares and no sales, exercises, gifts, or other dispositions in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Weeks Brad Allan

(Last)(First)(Middle)
C/O VIVOS INC.
1030 N CENTER PARKWAY

(Street)
KENNEWICK WASHINGTON 99336

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
VIVOS INC [ RDGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/16/2026P25,550A$0.0482(1)1,547,204D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.048 to $0.0489, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) of this Form 4.
/s/ Bradley Allan Weeks09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading